1,065
Participants
Start Date
June 10, 2021
Primary Completion Date
July 19, 2022
Study Completion Date
March 24, 2023
sotrovimab
Sotrovimab 500 mg given by intravenous infusion over 15 min
sotrovimab
Sotrovimab 500 mg given by intramuscular injection
sotrovimab
Sotrovimab 250 mg given by intramuscular injection
sotrovimab
Sotrovimab 2000 mg given by intravenous infusion over 60 min
Sotrovimab
Sotrovimab 2000 mg given by intravenous infusion over 30 min
Sotrovimab
Sotrovimab 2000 mg given by intravenous infusion over 15 min
Sotrovimab
Sotrovimab up to 3000 mg given by intravenous infusion over 90 min
Investigative Site, The Bronx
Investigative Site, Smithfield
Investigative Site, Mount Airy
Investigative Site, High Point
Investigative Site, Atlanta
Investigative Site, Ormond Beach
Investigative Site, Gainesville
Investigative Site, Hialeah
Investigative Site, Hialeah
Investigative Site, Hialeah
Investigative Sites, Pembroke Pines
Investigative Site, Miami
Investigative Site, Pompano Beach
Investigative Site, Miami
Investigative Site, Doral
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Palmetto Bay
Investigative Site, Doral
Investigative Site, North Miami Beach
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Tampa
Investigative Site, Tampa
Investigative Site, Bradenton
Investigative Site, Anniston
Investigative Site, Columbus
Investigative Site, Mishawaka
Investigative Site, Sterling Heights
Investigative Site, Forney
Investigative Site, Mesquite
Investigative Site, Houston
Investigative Site, Houston
Investigative Site, Houston
Investigative Site, Baytown
Investigative Site, Laredo
Investigative Site, Pharr
Investigative Site, Idaho Falls
Investigative Site, Mesa
Investigative Site, Tucson
Investigative Site, Limoges
Investigative Site, Las Vegas
Investigative Site, Los Angeles
Investigative Site, Rolling Hills Estates
Investigative Site, Kirkland
Investigative Site, Seattle
Investigative Site, Kyiv
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Vir Biotechnology, Inc.
INDUSTRY